Epinephrine is the medication of choice in the first-aid treatment of anaphylaxis in the
community. For ethical reasons, it is not possible to conduct randomized, placebo-controlled …

Airborne allergens are the major cause of allergic rhinitis and asthma. Daily exposure
comes from indoor sources, chiefly at home but occasionally at schools or offices. Seasonal …

This is the fourth iteration of this parameter entitled “The Diagnosis and Management of
Anaphylaxis.” The first anaphylaxis parameter was published in 1998 and the last in 2010 …

Abstract The illustrated World Allergy Organization (WAO) Anaphylaxis Guidelines were
created in response to absence of global guidelines for anaphylaxis. Uniquely, before they …

The unique World Allergy Organization (WAO) Guidelines for the Assessment and
Management of Anaphylaxis were created in response to the absence of global guidelines …

Kounis syndrome is potentially a life-threatening medical emergency with both a severe
allergic reaction and acute coronary syndrome. Most of the information about this syndrome …

Cardiovascular disease (CVD) increases the risk of severe or fatal anaphylaxis, and some
medications for CVD treatment can exacerbate anaphylaxis. The aim of this article is to …

Inflammatory mediators, adhesion molecules of neutrophils and monocytes, have been
shown to be increased in the plasma of patients presenting with acute coronary syndromes …

The clinical picture of myocardial ischemia accompanying allergic reactions is defined in the
cardiologic literature as Kounis syndrome (KS) or allergic angina/myocardial infarction. In …

Background Diclofenac is a widely used analgesic, anti-inflammatory, antipyretic drug. In
several case reports, its use was associated with the occurrence of Kounis syndrome. The …